
Virgin Atlantic: ‘100% Sustainable Aviation Fuel’
Ad regulator finds term potentially misleading in context of radio ad.
Brown et al. v. ZMB Enterprises LLC
22-cv-54, S.D. Cal.
(Jan. 2022)
XanRelax and Addall
Misleadingly labeling products as “dietary supplements” when they contain illegal ingredients and thus do not meet the definition of “dietary supplement” under federal law
Misleadingly using the name XanRelax to make consumers believe the product provides benefits similar to the prescription drug Xanax
Misleadingly using the name Addall to make consumers believe the product provides benefits similar to the prescription drug Adderall
Falsely marketing products as able to treat, cure, and prevent diseases, including depression, anxiety, and ADHD, and without FDA approval to do so
Pending
Ad regulator finds term potentially misleading in context of radio ad.
TINA.org reader says moving company failed to live up to its ads. She’s not the only one.
Why you can’t take this smartwatch “anywhere.”
Common ingredient raises potential health risks not always clearly disclosed in the marketing.
Former sales associate files lawsuit accusing luxury brand of greenwashing.